Pay in 4 interest-free payments of $37.50 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Ikarisoside A reduced the release of pro-inflammatory cytokines
4(7):e6286
PubMed PMID: 20981342
Upright NA
The use of sleep measures to compare a new 5HT1A agonist with buspirone in humans
RO-9187 1470 (methanesulfonate) Ikarisoside A reduced the releaseRO 9187 is a potent inhibitor of HCV virus replication in the replicon system (IC(50) = 171 + 12 nM; CC(50) >1 mM). RO 9187 is an excellent substrate for deoxycytidine kinase and is phosphorylated with efficiencies up to 3 fold higher than deoxycytidine. RO 9187 is a new class of antiviral nucleosides with promising preclinical properties as potential medicines for the treatment of HCV infection. Product information CAS Number: 876708 03 1 Molecular